The course of Toxoplasma gondii infection in rats closely resembles that in humans. However, compared to the Brown Norway (BN) rat, the Lewis (LEW) rat is extremely resistant to T. gondii infection. Thus, we performed RNA sequencing analysis of the LEW rat versus the BN rat, with or without T. gondii infection, in order to unravel molecular factors directing robust and rapid early T. gondii-killing mechanisms in the LEW rat. We found that compared to the uninfected BN rat, the uninfected LEW rat has inherently higher transcript levels of cytochrome enzymes (Cyp2d3, Cyp2d5, and Cybrd1, which catalyze generation of reactive oxygen species [ROS]), with concomitant higher levels of ROS. Interestingly, despite having higher levels of ROS, the LEW rat had lower transcript levels for antioxidant enzymes (lactoperoxidase, microsomal glutathione S-transferase 2 and 3, glutathione S-transferase peroxidase kappa 1, and glutathione peroxidase) than the BN rat, suggesting that the LEW rat maintains cellular oxidative stress that it tolerates. Corroboratively, we found that scavenging of superoxide anion by Mn(III) tetrakis (4-benzoic acid) porphyrin (MnTBAP) decreased the refractoriness of LEW rat peritoneal cells to T. gondii infection, resulting in proliferation of parasites in LEW rat peritoneal cells which, in turn, led to augmented cell death in the infected cells. Together, our results indicate that the LEW rat maintains inherent cellular oxidative stress that contributes to resistance to invading T. gondii, and they thus unveil new avenues for developing therapeutic agents targeting induction of host cell oxidative stress as a mechanism for killing T. gondii.KEYWORDS Brown Norway rat, cytochrome enzymes, Lewis rat, Toxoplasma gondii resistance, innate immunity, oxidative stress T oxoplasma gondii is a remarkably successful protozoan capable of infecting virtually all mammalian species, with about one-third of the world human population estimated to be infected. T. gondii infection and clinical outcome vary among species (1), depending on, among others, the immune status and genetic predisposition of the host (2-4). Unlike mice, rats are known to resist the development of clinical toxoplasmosis upon infection with T. gondii (5, 6). The phenomenon of T. gondii infection in rats closely mirrors the clinical progression of the infection in immunocompetent humans (7,8). This resemblance in the progression of toxoplasmosis between rats and humans warrants the use of rats as quintessential animal models for elucidating T. gondii infection in humans (7,8).Among rat strains, variations in resistance/susceptibility to toxoplasmosis have been reported. For instance, compared to the Brown Norway (BN) rat, the Lewis (LEW) rat is extremely resistant to T. gondii infection (9). This refractoriness of the LEW rat to toxoplasmosis has been associated with a rat genomic locus named Toxo1 on chromosome 10 (10). Pursuant to this, two genes called NLRP1 and ALOX1 in the orthologous Toxo1 locus on chromosome 17 in the human genome...